Patents by Inventor Qingling LIU

Qingling LIU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIAGNOSTIC KIT FOR METASTASIS AND INVASION OF BREAST CANCER AND USE OF shRNA MOLECULE FOR SILENCING EXPRESSION OF HUMAN LINC01614
    Publication number: 20240124880
    Abstract: The invention provides a diagnostic kit for metastasis and invasion of breast cancer and a use of an shRNA molecule for silencing expression of human LINC01614. The shRNAs obtained by the invention can interfere with the expression of LINC01614, thereby reducing the migration and invasion ability of tumor cells, inhibiting the expression of EMT proteins, and inhibiting tumor formation and lung metastasis in an animal model in vivo. The invention provides a new solution for targeted therapy of breast cancer. Therefore, the kit for diagnosing metastasis and invasion of breast cancer and the medication for treating metastasis and invasion of breast cancer are developed. The invention provides a new way and strategy for diagnosing and treating metastasis and invasion of breast cancer.
    Type: Application
    Filed: November 29, 2023
    Publication date: April 18, 2024
    Applicant: Zhejiang Chinese Medical University
    Inventors: Fangfang TAO, Zhiqian ZHANG, Wenhong LIU, Ye XU, Qingling LIU, Junfeng LI
  • Medication and diagnostic kit for inhibiting metastasis and invasion of breast cancer, shRNA molecule for silencing expression of human LINC01614 and application thereof
    Patent number: 11873492
    Abstract: The invention provides a medication and a diagnostic kit for inhibiting metastasis and invasion of breast cancer, an shRNA molecule for silencing expression of human LINC01614 and applications thereof. The shRNAs obtained by the invention can interfere with the expression of LINC01614, thereby reducing the migration and invasion ability of tumor cells, inhibiting the expression of EMT proteins, and inhibiting tumor formation and lung metastasis in an animal model in vivo. The invention provides a new solution for targeted therapy of breast cancer. Therefore, the kit for diagnosing metastasis and invasion of breast cancer and the medication for treating metastasis and invasion of breast cancer are developed. The invention provides a new way and strategy for diagnosing and treating metastasis and invasion of breast cancer.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: January 16, 2024
    Assignee: Zhejiang Chinese Medical University
    Inventors: Fangfang Tao, Zhiqian Zhang, Wenhong Liu, Ye Xu, Qingling Liu, Junfeng Li
  • MEDICATION AND DIAGNOSTIC KIT FOR INHIBITING METASTASIS AND INVASION OF BREAST CANCER, shRNA MOLECULE FOR SILENCING EXPRESSION OF HUMAN LINC01614 AND APPLICATION THEREOF
    Publication number: 20230174986
    Abstract: The invention provides a medication and a diagnostic kit for inhibiting metastasis and invasion of breast cancer, an shRNA molecule for silencing expression of human LINC01614 and applications thereof. The shRNAs obtained by the invention can interfere with the expression of LINC01614, thereby reducing the migration and invasion ability of tumor cells, inhibiting the expression of EMT proteins, and inhibiting tumor formation and lung metastasis in an animal model in vivo. The invention provides a new solution for targeted therapy of breast cancer. Therefore, the kit for diagnosing metastasis and invasion of breast cancer and the medication for treating metastasis and invasion of breast cancer are developed. The invention provides a new way and strategy for diagnosing and treating metastasis and invasion of breast cancer.
    Type: Application
    Filed: June 29, 2022
    Publication date: June 8, 2023
    Applicant: Zhejiang Chinese Medical University
    Inventors: Fangfang TAO, Zhiqian ZHANG, Wenhong LIU, Ye XU, Qingling LIU, Junfeng LI
  • Mixed template synthesis of low silica CHA zeolite
    Patent number: 11266981
    Abstract: A transition-metal-CHA molecular sieve catalyst and mixed-template synthesis procedure are disclosed.
    Type: Grant
    Filed: December 2, 2014
    Date of Patent: March 8, 2022
    Assignee: Johnson Matthey Public Limited Company
    Inventors: Alejandra Rivas-Cardona, Joseph Michael Fedeyko, Hai-Ying Chen, Raul Francisco Lobo, Eric Burkholder, Qingling Liu
  • MIXED TEMPLATE SYNTHESIS OF LOW SILICA CHA ZEOLITE
    Publication number: 20150151286
    Abstract: A transition-metal-CHA molecular sieve catalyst and mixed-template synthesis procedure are disclosed.
    Type: Application
    Filed: December 2, 2014
    Publication date: June 4, 2015
    Inventors: Alejandra RIVAS-CARDONA, Joseph Michael FEDEYKO, Hai-Ying CHEN, Raul Francisco LOBO, Eric BURKHOLDER, Qingling LIU